| The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019) S Umemura, H Arima, S Arima, K Asayama, Y Dohi, Y Hirooka, T Horio, ... Hypertension Research 42 (9), 1235-1481, 2019 | 1239 | 2019 |
| Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant … K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy, R Ramakrishnan, ... The Lancet 397 (10285), 1625-1636, 2021 | 499 | 2021 |
| A new classification of diabetic nephropathy 2014: a report from joint committee on diabetic nephropathy M Haneda, K Utsunomiya, D Koya, T Babazono, T Moriya, H Makino, ... Clinical and Experimental Nephrology 19, 1-5, 2015 | 340 | 2015 |
| Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis H Okada, T Kikuta, T Kobayashi, T Inoue, Y Kanno, M Takigawa, ... Journal of the American Society of Nephrology 16 (1), 133-143, 2005 | 285 | 2005 |
| Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD H Suzuki, Y Kanno, S Sugahara, H Okada, H Nakamoto American journal of kidney diseases 43 (6), 1056-1064, 2004 | 270 | 2004 |
| Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial H Suzuki, Y Kanno, S Sugahara, N Ikeda, J Shoda, T Takenaka, T Inoue, ... American journal of kidney diseases 52 (3), 501-506, 2008 | 221 | 2008 |
| A case–control study of calciphylaxis in Japanese end-stage renal disease patients M Hayashi, I Takamatsu, Y Kanno, T Yoshida, T Abe, Y Sato Nephrology Dialysis Transplantation 27 (4), 1580-1584, 2012 | 215 | 2012 |
| Hepatocyte growth factor counteracts transforming growth factor‐β1, through attenuation of connective tissue growth factor induction, and prevents renal … T Inoue, H Okada, T Kobayashi, Y Watanabe, Y Kanno, JB Kopp, ... The FASEB Journal 17 (2), 268-270, 2003 | 178 | 2003 |
| Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual … K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy, M Wamil, J Majert, ... The lancet 398 (10305), 1053-1064, 2021 | 156 | 2021 |
| Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. H Oguchi, M Miyasaka, S Tokunaga, K Hora, S Ichikawa, T Ochi, ... Clinical nephrology 38 (1), 36-43, 1992 | 153 | 1992 |
| Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis H Nemoto, H Nakamoto, H Okada, S Sugahara, K Moriwaki, M Arai, ... Blood purification 19 (4), 361-369, 2001 | 142 | 2001 |
| Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients A Ichihara, M Hayashi, Y Kaneshiro, T Takemitsu, K Homma, Y Kanno, ... American journal of kidney diseases 45 (5), 866-874, 2005 | 110 | 2005 |
| Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study E Kanda, T Muneyuki, Y Kanno, K Suwa, K Nakajima PloS one 10 (2), e0118031, 2015 | 101 | 2015 |
| Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. Y Kanno, H Okada, T Saruta, H Suzuki Clinical nephrology 54 (5), 360-365, 2000 | 100 | 2000 |
| Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients H Suzuki, Y Kanno Hypertension research 28 (4), 307-314, 2005 | 93 | 2005 |
| Connective tissue growth factor mediates the profibrotic effects of transforming growth factor-β produced by tubular epithelial cells in response to high glucose T Kobayashi, T Inoue, H Okada, T Kikuta, Y Kanno, T Nishida, ... Clinical and experimental nephrology 9, 114-121, 2005 | 91 | 2005 |
| Short-and long-term prognosis of blood pressure and kidney disease in women with a past history of preeclampsia H Suzuki, Y Watanabe, H Arima, K Kobayashi, Y Ohno, Y Kanno Clinical and experimental nephrology 12, 102-109, 2008 | 87 | 2008 |
| Expression and role of connexins in the rat renal vasculature T Takenaka, T Inoue, Y Kanno, H Okada, KR Meaney, CE Hill, H Suzuki Kidney international 73 (4), 415-422, 2008 | 87 | 2008 |
| Qualification of arterial stiffness as a risk factor to the progression of chronic kidney diseases T Takenaka, T Mimura, Y Kanno, H Suzuki American journal of nephrology 25 (5), 417-424, 2005 | 80 | 2005 |
| A selective angiotensin receptor antagonist, Valsartan, produced regression of left ventricular hypertrophy associated with a reduction of arterial stiffness. H Suzuki, H Nakamoto, H Okada, S Sugahara, Y Kanno Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 19, 59-66, 2003 | 76 | 2003 |
Norihisa MikiKeio University, Department of Mechanical EngineeringVerified email at mech.keio.ac.jp
